Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
Browse by type, application, or key specifications such as purity, grade, packaging, and handling requirements.
39 products
Popular Products
- GSK872CAS: 1346546-69-7 Formula: C19H17N3O2S2 Molecular Weight: 383.48Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%In Stock Item #: G276439View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- N-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine
- SMILES
- CC(C)S(=O)(=O)C1=CC2=C(C=CN=C2C=C1)NC3=CC4=C(C=C3)SC=N4
- InChIKey
- ZCDBTQNFAPKACC-UHFFFAOYSA-N
- InChI
- 1S/C19H17N3O2S2/c1-12(2)26(23,24)14-4-5-16-15(10-14)17(7-8-20-16)22-13-3-6-19-18(9-13)21-11-25-19/h3-12H,1-2H3,(H,20,22)
- Synonyms
- GSK′872 | N-(6-(Isopropylsulfonyl)quinolin-4-yl)benzo[d]thiazol-5-amine
- GSK 583, Inhibitor of receptor interacting serine/threonine kinase 2CAS: 1346547-00-9 Formula: C20H19FN4O2S Molecular Weight: 398.45Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%(HPLC)In Stock Item #: G286537View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 6-tert-butylsulfonyl-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine
- SMILES
- CC(C)(C)S(=O)(=O)C1=CC2=C(C=CN=C2C=C1)NC3=NNC4=C3C=C(C=C4)F
- InChIKey
- XLOGLWKOHPIJLV-UHFFFAOYSA-N
- InChI
- 1S/C20H19FN4O2S/c1-20(2,3)28(26,27)13-5-7-16-14(11-13)17(8-9-22-16)23-19-15-10-12(21)4-6-18(15)24-25-19/h4-11H,1-3H3,(H2,22,23,24,25)
- Synonyms
- GSK 583 | GSK-2616583A
- LY2157299, TGF-beta receptor type I inhibitorMoligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%In Stock Item #: L126937View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide
- SMILES
- CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N
- InChIKey
- IVRXNBXKWIJUQB-UHFFFAOYSA-N
- InChI
- 1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28)
- Synonyms
- BDBM50015640 | 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[2,1-e]pyrazol-3-yl]quinoline-6-carboxamide | MFCD00...
- Necrostatin-1, Inhibitor of indoleamine 2;3-dioxygenase 1;Inhibitor of receptor interacting serine/threonine kinase 1CAS: 4311-88-0 Formula: C13H13N3OS Molecular Weight: 259.33Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%In Stock Item #: N125522View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanylideneimidazolidin-4-one
- SMILES
- CN1C(=O)C(NC1=S)CC2=CNC3=CC=CC=C32
- InChIKey
- TXUWMXQFNYDOEZ-UHFFFAOYSA-N
- InChI
- 1S/C13H13N3OS/c1-16-12(17)11(15-13(16)18)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,14H,6H2,1H3,(H,15,18)
- Synonyms
- 5-(1H-indol-3-ylmethyl)-3-methyl-2-sulfanyl-3,5-dihydro-4H-imidazol-4-one | 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo...
- Varlitinib, Receptor protein-tyrosine kinase erbB-2 inhibitorCAS: 845272-21-1 EC Number: 807-347-4 PubChem CID: 42642648 Formula: C22H19ClN6O2S Molecular Weight: 466.94Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥96%In Stock Item #: V129433View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine
- SMILES
- CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl
- InChIKey
- UWXSAYUXVSFDBQ-CYBMUJFWSA-N
- InChI
- show more
- Synonyms
- 4,6-Quinazolinediamine, N(sup 4)-(3-chloro-4-(2-thiazolylmethoxy)phenyl)-N(sup 6)-((4R)-4,5- dihydro-4-methyl-2-oxazo...
- Dabrafenib, Inhibitor of B-Raf proto-oncogene; serine/threonine kinaseMoligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%In Stock Item #: D127289View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
- SMILES
- CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F
- InChIKey
- BFSMGDJOXZAERB-UHFFFAOYSA-N
- InChI
- show more
- Synonyms
- GSK-2118436A | GSK-2118436 | AKOS024463285 | CCG-264736 | N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-t...
- GNF-7In Stock Item #: G177569View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- N-[4-methyl-3-[1-methyl-7-[(6-methylpyridin-3-yl)amino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-3-yl]phenyl]-3-(trifluoromethyl)benzamide
- SMILES
- CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)N3CC4=CN=C(N=C4N(C3=O)C)NC5=CN=C(C=C5)C
- InChIKey
- SZNYUUZOQHNEKB-UHFFFAOYSA-N
- InChI
- show more
- Synonyms
- N-(4-Methyl-3-(1-methyl-7-(6-methylpyridin-3-ylamino)-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)phenyl)-3-(t...
- Apatinib10mM in DMSOIn Stock Item #: A426102View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- N-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide
- SMILES
- C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4
- InChIKey
- WPEWQEMJFLWMLV-UHFFFAOYSA-N
- InChI
- show more
- Synonyms
- AKOS024464453 | N-(4-(1-cyanocyclopentyl)phenyl)-2-(pyridin-4-ylmethylamino)nicotinamide | BA175030 | HY-13342A | Apa...
- Dabrafenib (GSK2118436), Inhibitor of B-Raf proto-oncogene; serine/threonine kinaseMoligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSOIn Stock Item #: D409111View ProductPricing & Pack Sizes
Technical Identifiers
- Synonyms
- GSK2118436A | N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
- GNF-710mM in DMSOIn Stock Item #: G426182View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- N-[4-methyl-3-[1-methyl-7-[(6-methylpyridin-3-yl)amino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-3-yl]phenyl]-3-(trifluoromethyl)benzamide
- SMILES
- CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)N3CC4=CN=C(N=C4N(C3=O)C)NC5=CN=C(C=C5)C
- InChIKey
- SZNYUUZOQHNEKB-UHFFFAOYSA-N
- InChI
- show more
- Synonyms
- N-(4-Methyl-3-(1-methyl-7-(6-methylpyridin-3-ylamino)-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)phenyl)-3-(t...
- GSK 583, Inhibitor of receptor interacting serine/threonine kinase 2CAS: 1346547-00-9 Formula: C20H19FN4O2S Molecular Weight: 398.45Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSOIn Stock Item #: G421308View ProductPricing & Pack Sizes
Technical Identifiers
- IUPAC Name
- 6-tert-butylsulfonyl-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine
- SMILES
- CC(C)(C)S(=O)(=O)C1=CC2=C(C=CN=C2C=C1)NC3=NNC4=C3C=C(C=C4)F
- InChIKey
- XLOGLWKOHPIJLV-UHFFFAOYSA-N
- InChI
- 1S/C20H19FN4O2S/c1-20(2,3)28(26,27)13-5-7-16-14(11-13)17(8-9-22-16)23-19-15-10-12(21)4-6-18(15)24-25-19/h4-11H,1-3H3,(H2,22,23,24,25)
- Synonyms
- 6-[(1,1-Dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)-4-quinolinamine
- GSK'872 (GSK2399872A)CAS: 1346546-69-7 Formula: C19H17N3O2S2 Molecular Weight: 383.4810mM in DMSOIn Stock Item #: G409176View ProductPricing & Pack Sizes
Technical Identifiers
- Synonyms
- 4-Quinolinamine, N-5-benzothiazolyl-6-[(1-methylethyl)sulfonyl]-
Fast Shipping Same-day shipping on in-stock items
Technical Details Quality & specification info on every product page
Pack Size Options Multiple packaging sizes with pricing access from listing
R&D Use Only Products supplied for research and development use












